Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(antiprotozoal)
182,070 results
  • Antiprotozoal Activity against Entamoeba histolytica of Flavonoids Isolated from Lippia graveolens Kunth. [Journal Article]
    Molecules. 2020 May 26; 25(11)Quintanilla-Licea R, Vargas-Villarreal J, … Torres-Hernández ÁD
  • Amebiasis caused by Entamoeba histolytica is nowadays a serious public health problem worldwide, especially in developing countries. Annually, up to 100,000 deaths occur across the world. Due to the resistance that pathogenic protozoa exhibit against commercial antiprotozoal drugs, a growing emphasis has been placed on plants used in traditional medicine to discover new antiparasitics. Previously…
  • COVID-19 and lung cancer: risks, mechanisms and treatment interactions. [Journal Article]
    J Immunother Cancer. 2020 05; 8(1)Addeo A, Obeid M, Friedlaender A
  • Cases of the 2019 novel coronavirus also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to rise worldwide. To date, there is no effective treatment. Clinical management is largely symptomatic, with organ support in intensive care for critically ill patients. The first phase I trial to test the efficacy of a vaccine has recently begun, but in the meantime there is a…
  • Research Progress of Drug Treatment in Novel Coronavirus Pneumonia. [Review]
    AAPS PharmSciTech. 2020 May 13; 21(4):130.Yan J, Liu A, … Fan H
  • As of March 10, 2020, more than 100,000 novel coronavirus pneumonia cases have been confirmed globally. With the continuous spread of the new coronavirus pneumonia epidemic in even the world, prevention and treatment of the disease have become urgent tasks. The drugs currently being developed are not adequate to deal with this critical situation. In addition to being controlled through effective …
  • [Long-term travelers to malaria endemic areas : What prevention strategies ?] [Review]
    Rev Med Suisse. 2020 May 13; 16(693):978-983.Miauton A, Genton B
  • Long-term travelers are particularly exposed to malaria. It is essential to inform them about this risk, the recognition of the symptoms of the disease and the need for prompt treatment. Addressing any fears of travelers and answering their questions improve therapeutic adherence. Personal protective measures (repellents, mosquito nets) are fundamental and safe to reduce exposure to the vector of…
  • [Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection]. [Review]
    Ugeskr Laeger. 2020 05 11; 182(20)Troldborg A, Bartels LE, Deleuran B
  • The severity of COVID-19 disease has led to an urgent need for the discovery of new treatments. Thus, global stocks of hydroxychloroquine (HCQ) have been put under pressure with a study of 26 patients treated with HCQ during their infection with SARS-CoV-2. Despite the study's lack of quality, several countries' medicines agencies subsequently issued guidelines for the use of HCQ for COVID-19. Th…
  • [Chloroquine as a possible treatment for COVID-19]. [Journal Article]
    Ned Tijdschr Geneeskd. 2020 Mar 11; 164Coumou J, de Vries PJ
  • Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment. In vitro studies have shown anti-viral activity of chloroquine against SARS-CoV-2. Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdes…
  • Novel coronavirus 2019 (COVID-19): A case report and review of treatments. [Case Reports]
    Medicine (Baltimore). 2020 May; 99(19):e20207.Douedi S, Miskoff J
  • CONCLUSIONS: With a rapidly growing death rate and more than 200,000 confirmed cases worldwide, COVID-19 has become a global pandemic and major hit to our healthcare systems. While several companies have already begun vaccine trials and healthcare facilities have been using a wide-range of medications to treat the virus and symptoms, there is not yet an approved medication regimen for COVID-19 infections. The alarming increase in cases per day adds additional pressure to find a cure and decrease the global health burden and mortality rate.
New Search Next